Resultados de la búsqueda 861-870 of 10575 for 14-day walking program

  1. Ensayos clínicos - Medicina cardiovascular

    The purpose of this study is to derive and characterize patient-specific disease models for sudden death-predisposing heritable channelopathies and ...

  2. Centro Pediátrico de Mayo Clinic

    The aim of this study is to test the validity of the current question database in a large cohort of children with Inflammatory Bowel Disease (IBD) in several ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate olaparib and temozolomide in treating patients with uterine leiomyosarcoma (LMS) that has spread to other places of ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates ...

  5. Oncología (médica) - Ensayos clínicos

    ... day turnaround time for biopsy results in Stage I of the study. Also, to evaluate the feasibility of molecular characterization based on TMB and gene ...

  6. Neurocirugía - Ensayos clínicos

    ... days prior to the end of the current therapy cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle ...

  7. Nutrición y comida saludable Natural family planning - Mayo Clinic

    USDA National Organic Program. Hay un problema con la información enviada en la solicitud. Revise o actualice la información resaltada a continuación y ...

  8. Trastornos del movimiento - Médicos y departamentos - Mayo Clinic

    Departamentos y especialidades. Mayo Clinic tiene uno de los centros médicos más grandes y experimentados en los Estados Unidos, con sedes en Arizona, ...

  9. Hematología - Ensayos clínicos

    Jacksonville, Fla. The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for ...

  10. Oncología (médica) - Ensayos clínicos

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...